Molecular Interaction Fields in ADME and Safety

Molecular Interaction Fields: Applications in Drug Discovery and ADME Prediction

Volumn 27, Issue , 2006, Pages 197-218

  Cianchetta, Giovanni ^a   Li, Yi ^b   Singleton, Robert ^b   Zhang, Meng ^b   Wildgoose, Marianne ^b   Rampe, David ^b   Kang, Jiesheng ^b   Vaz, Roy J ^b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b SANOFI   (France)

Author keywords

CYP 3A4 inhibition; GRID and MIFs; HERG inhibition; Molecular interaction fields in ADME and safety; Role of Pgp efflux in the absorption

Indexed keywords

MOLECULAR STRUCTURE;

GRID AND MIFS; MOLECULAR INTERACTION FIELDS;

MOLECULAR INTERACTIONS;

EID: 85018232010     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/3527607676.ch9     Document Type: Chapter

References (51)

1. Goodford, P. J. A computational procedure for determining energetically favorable binding sites on biological important macromolecules, J. Med. Chem. 1985, 28, 849-857.
2. Fontaine, F.; Pastor, M.; Sanz, F. Incorporating Molecular Shape into the Alignment-free GRid-INdependent Descriptors, J. Med. Chem. 2004, 47, 2805-2815.
3. Reference to our work
4. Saeki T.; Ueda K.; Tanigawara Y.; Hori R.; Komano, T. Human Pglycoprotein transports cyclosporin A and FK506, J. Biol. Chem. 1993, 268, 6077-6080.
5. Sybyl Molecular Modeling System (version 6.9.2) Tripos Inc.; St. Louis; MO.
6. Martin, Y. C. 3D Database Searching in Drug Design, J. Med. Chem. 1992, 35, 2145-2154.
7. Pearlman, R. S. 3D Molecular Structure: Generation and Use in 3D Searching, in 3D QSAR in Drug Design-Theory Methods and Applications, Kubyni, H. Ed., Escom Science Publishers, Leiden, 1993, pp. 41-79.
8. MOETM, www.chemcomp.com/Corpor-ate_Information/MOE.html
9. Wold, S.; Esbensen, K.; Geladi, P. Principal component analysis, Chemom. Intell. Lab. Syst. 1987, 2, 37-52.
10. Shapiro, A. B.; Ling, V. The Mechanism of ATP-Dependent Multidrug Transport by P-Glycoprotein, Acta. Physiol. Scand. 1993, 163, Suppl 643, 227-234.
11. Seelig, A.; Landwojtowicz, E. Structure-activity Relationship of P-glycoprotein substrates and modifiers, Eur. J. Pharm. Sci. 2000, 12, 31-40.
12. Higgins, C. F.; Linton, K. J. The ATP switch model for ABC transporters, Nat. Struct. Mol. Biol. 2004, 11, 918-926.
13. Dey, S.; Ramachandra, M.; Pastan, I.; Gottesman, M. M.; Ambudkar, S. V. Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein, Proc. Natl. Acad. Sci. USA 1997, 94, 10594-10599.
14. Homolya, L.; Hollo, Z.; Germann, U. A.; Pastan, I.; Gottesman, M. M.; Sarkadi, B. Fluorescent cellular indicators are extruded by the multidrug resistance protein, J. Biol. Chem. 1993, 268, 21493-21496.
15. Stein, W. D. Kinetics of the multidrug transporter (P-glycoprotein) and its reversal, Physiol. Rev. 1997, 77, 545-590.
16. Kang, J.; Wang, L.; Cai, F.; Rampe, D. Eur. J. Pharmacol. 2000, 392, 137-140.
17. Pearlstein, R. A.; Vaz, R. J.; Kang, J.; Chen, X. L.; Preobrazhenskaya, M.; Shchekotikhin, A. E.; Korolev, A. M.; Lysenkova, L. N.; Miroshnikova, O. V.; Hendrix, J.; Rampe, D. Bioorg. Med. Chem. Lett. 2003, 13, 1829-1835.
18. Cerep, BioPrint® database (http://www.cerep.fr).
19. Lin, Y.; Lu, P.; Tang, C.; Mei, Q.; Sandig, G. ; Rodrigues, A. D.; Rushmore, T. H.; Shou, M. Drug Metab. Dispos. 2001, 29, 368-374.
20. Williams, P. A.; Cosme, J.; Vinkovic, D. M.; Ward, A.; Angove, H. C.; Day, P. J.; Vonrhein, C.; Tickle, I. J.; Jhoti, H. Science 2004, 305, 683-686.
21. Yano, J. K.; Wester, M. R.; Schoch, G. A.; Griffin, K. J.; Stout, C. D.; Johnson, E. F. J. Biol. Chem. 2004, 279, 38091-38094.
22. Scott, E. E.; He, Y. A.; Wester, M. R.; White, M. A.; Chin, C. C.; Halpert, J. R.; Johnson, E. F.; Stout, C. D. Proc. Natl. Acad. Sci. USA 2003, 100, 13196-13201.
23. Riley, R. J.; Parker, A. J.; Trigg, S.; Manners, C. N. Pharm. Res. 2001, 18, 652-655.
24. Crivori, P.; Zamora, I.; Speed, B.; Orrenius, C.; Poggesi, I. J. Comput. Aided Mol. Des. 2004, 18, 155-166.
25. Domanski, T. L.; He, Y. A.; Harlow, G. R.; Halpert, J. R. J. Pharmacol. Exp. Ther. 2000, 293, 585-591.
26. Harlow, G. R.; Halpert, J. R. Proc. Natl. Acad. Sci. USA 1998, 95, 6636-6641.
27. Ueng, Y. F.; Kuwabara, T.; Chun, Y. J.; Guengerich, F. P. Biochemistry 1997, 36, 370-381.
28. Buening, M. K.; Fortner, J. G.; Kappas, A.; Corney, A. H. Biochem. Biophys. Res. Commun. 1978, 82, 348-355.
29. Huang, M. T.; Johnson, E. F.; Muller-Eberhard, U.; Koop, D. R.; Coon, M. J.; Conney, A. H. J. Biol. Chem. 1981, 256, 10897-10901.
30. Thakker, D. R.; Levin, W.; Buening, M.; Yagi, H.; Lehr, R. E.; Wood, A. W.; Conney, A. H.; Jerina, D. M. Cancer Res. 1981, 41, 1389-1396.
31. Kapitulnik, J.; Poppers, P. J.; Buening, M. K.; Fortner, J. G.; Conney, A. H. Clin. Pharmacol. Ther. 1977, 22, 475-484.
32. Schwab, G. E.; Raucy, J. L.; Johnson, E. F. Mol. Pharmacol. 1988, 33, 493-499.
33. Lee, C. A.; Lillibridge, J. H.; Nelson, S. D.; Slattery, J. T. J. Pharmacol. Exp. Ther. 1996, 277, 287-291.
34. Wang, R. W.; Newton, D. J.; Scheri, T. D.; Lu, A. Y. Drug Metab. Dispos. 1997, 25, 502-507.
35. Domanski, T. L.; Liu, J.; Harlow, G. R.; Halpert, J. R. Arch. Biochem. Biophys. 1998, 350, 223-232.
36. Ludwig, E.; Schmid, J.; Beschke, K.; Ebner, T. J. Pharmacol. Exp. Ther. 1999, 290, 1-8.
37. Lee, C. A.; Manyike, P. T.; Thummel, K. E.; Nelson, S. D.; Slattery, J. T. Drug Metab. Dispos. 1997, 25, 1150-1156.
38. Hosea, N. A.; Miller, G. P.; Guengerich, F. P. Biochemistry 2000, 39, 5929-5939.
39. Domanski, T. L.; He, Y. A.; Harlow, G. R.; Halpert, J. R. J. Pharmacol. Exp. Ther. 2000, 293, 585-591.
40. Korzekwa, K. R.; Krishnamachary, N.; Shou, M.; Ogai, A.; Parise, R. A.; Rettie, A. E.; Gonzalez, F. J.; Tracy, T. S. Biochemistry 1998, 37, 4137-4147.
41. Shou, M.; Grogan, J.; Mancewicz, J. A.; Krausz, K. W.; Gonzalez, F. J.; Gelboin, H. V.; Korzekwa, K. R. Biochemistry 1994, 33, 6450-6455.
42. Shou, M.; Mei, Q.; Ettore, M. W., Jr.; Dai, R.; Baillie, T. A.; Rushmore, T. H. Biochem. J. 1999, 340 (3), 845-853.
43. Ueng, Y. F.; Kuwabara, T.; Chun, Y. J.; Guengerich, F. P. Biochemistry 1997, 36, 370-381.
44. Schwab, G. E.; Raucy, J. L.; Johnson, E. F. Mol. Pharmacol. 1988, 33, 493-499.
45. Kenworthy, K. E.; Clarke, S. E.; Andrews, J.; Houston, J. B. Drug Metab. Dispos. 2001, 29, 1644-1651
46. Baasa, B. J.; Denisov, I. G.; Sligar, S. G. Arch. Biochem. Biophys. 2004, 430, 218-228.
47. Scott, E. E.; He, Y. A.; Wester, M. R.; White, M. A.; Chin, C. C.; Halpert, J. R.; Johnson, E. F.; Stout, C. D. Proc. Natl. Acad. Sci. USA 2003, 100, 13196-13201.
48. Scott, E. E.; White, M. A.; He, Y. A.; Johnson, E. F.; Stout, C. D.; Halpert, J. R. J. Biol. Chem. 2004, 279, 27294-27301.
49. Kenworthy, K. E.; Bloomer, J. C.; Clarke, S. E.; Houston, J. B. Br. J. Clin. Pharmacol. 1999, 48, 716-727.
50. Wang, R. W.; Newton, D. J.; Liu, N.; Atkins, W. M.; Lu, A. Y. Drug Metab. Dispos. 2000, 28, 360-366.
51. Stresser, D. M.; Blanchard, A. P.; Turner, S. D.; Erve, J. C.; Dandeneau, A. A.; Miller, V. P.; Crespi, C. L. Drug Metab. Dispos. 2000, 28, 1440-1448.